Tag:
Terumo
Latest Headlines
Latest Headlines
Terumo prevails in patent suit against Vascular Solutions
Terumo has prevailed in a patent spat with Vascular Solutions, and the latter company will stop manufacturing and selling a device Terumo said infringed on its intellectual property.
BSD turns to Terumo in global ablation device distribution deal
BSD Medical inked a wide-ranging deal with Japanese med tech giant Terumo to distribute one of its signature tumor ablation devices in Europe, Western Asia and North Africa.
Terumo matches Abbott's Xience in drug-eluting stent study
Terumo's drug-eluting stent, Nobori, nabbed a bit of Abbott Laboratories' Xience glory as it proved in a large study to be just as effective as the top-selling American brand.
Medtronic, Edwards headline this year's ACC news
The American College of Cardiology's annual scientific summit made for a busy weekend in the medical device world. We've rounded up some highlights from the annual expo.
Terumo ditches Boston Scientific for solo urology effort
Terumo is striking out on its own in the urology market, announcing that it will terminate its distribution deal with Boston Scientific and take on U.S. sales of its Glidewire Hydrophilic Guidewire products.
Biosensors Int'l, Terumo, will market Nobori stent in Japan
Switzerland's Biosensors International will work with Japan's Terumo to promote that company's Nobori drug-eluting stent in Japan.
Terumo, Biosensors Int'l, renew stent tech licensing deal through 2014
Japanese device maker Terumo has extended a crucial licensing deal through 2014, an agreement that will be important for the company's drug-eluting stent sales in global markets.
Olympus slapped with DOJ inquiries, Terumo shareholder lawsuit
Japan's Olympus ($OCPNY)--an endoscope giant also known for its cameras--is facing problems on multiple fronts today.
Device giant Terumo seeks merger with Olympus
Japanese devicemaker Terumo is proposing a merger with Olympus, following similar moves by Sony and Fujifilm, The Wall Street Journal and Bloomberg are reporting.
Terumo unit enters consent decree, gives up $35M in profits
A U.S. unit of Tokyo-based Terumo has agreed to the terms of a consent decree with the FDA regarding quality system improvements at an Ann Arbor, MI facility. Terumo Cardiovascular Systems also has
